Fedratinib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Fedratinib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Fedratinib included in the composition |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 79% Ruxolitinib
- 58% Busulfan
- 43% Fibrinogen+Thrombin [Trombin]
- 43% Trombin
- 42% Serotonin
- 40% Eltrombopag
- 37% Romiplostim
- 28% Regorafenib
- 28% Ibrutinib
- 27% Zanubrutinib
- 27% Sunitinib
- 27% Erlotinib
- 26% Dasatinib
- 26% Pazopanib
- 26% Abemaciclib
- 26% Cabozantinib
- 25% Trametinib
- 25% Imatinib
- 25% Nintedanib
- 25% Lorlatinib
- 25% Encorafenib
- 25% Selpercatinib
- 24% Aminomethylbenzoic acid
- 24% Palbociclib
- 24% Akalabrutinib
- 24% Axitinib
- 24% Alectinib
- 22% Bosutinib
- 21% Binimetinib
- 21% Vandetanib
- 21% Capivasertib
- 20% Eptacog alfa (activated)
- 19% Ribociklib
- 19% Osimertinib
- 19% Prodimin
- 19% Ceritinib
- 19% Nilotinib
- 19% Capmatinib
- 19% Afatinib
- 18% Hydroxycarbamide
- 18% Crizotinib
- 16% Thymostimulin
- 16% Cobimetinib
- 16% Immunoglobulin human normal
- 16% Etamsylate
- 16% Vemurafenib
- 16% Gilteritinib
- 16% Dabrafenib
- 16% Lapatinib
- 16% Midostaurin
Learn more about the selection of analogues
▶
- The drug has «Fedratinib» 51 analog by action, the most similar - Ruxolitinib .
- Medical online service has selected the best substitutes for Fedratinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Fedratinib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.